{"id":"W4410252080","doi":"10.3390/ph18050700","title":"Repurposing Sigma-1 Receptor-Targeting Drugs for Therapeutic Advances in Neurodegenerative Disorders","year":2025,"lang":"en","type":"review","venue":"Pharmaceuticals","topic":"Pharmacological Receptor Mechanisms and Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Concordia University; Université du Québec à Montréal","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Repurposing; Sigma-1 receptor; Medicine; Neuroprotection; Drug repositioning; Drug development; Pharmacology; Context (archaeology); Drug; Fluvoxamine; Receptor; Biology; Fluoxetine; Agonist","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007656885,0.0006081976,0.001166396,0.0001396349,0.0001486551,0.00004873639,0.0004530954,0.000427583,0.00007582957],"category_scores_gemma":[0.0004204872,0.0005004244,0.0005958236,0.0003323734,0.00008533237,0.00001290283,0.0002181447,0.0004555228,0.00001043035],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006905467,"about_ca_system_score_gemma":0.0002172822,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":8.789901e-7,"about_ca_topic_score_gemma":0.000001767288,"domain_scores_codex":[0.9967841,0.0006273954,0.0006846326,0.001035148,0.000167375,0.0007013422],"domain_scores_gemma":[0.9986448,0.0006273424,0.0002470972,0.0002574868,0.00006042013,0.0001628499],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008195292,0.0001154238,0.000001015339,0.006091407,0.00009845411,9.510064e-7,0.00001708149,0.0000307033,0.005906479,0.0002168748,0.001024483,0.9864151],"study_design_scores_gemma":[0.0005934442,0.0001566021,4.266496e-8,0.001515476,0.0003118621,8.942932e-7,0.00001454673,0.00009707946,0.01121362,0.0002799943,0.9852962,0.000520192],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000231977,0.9926035,0.002864517,0.00007086557,0.001037265,0.002543553,0.0001029127,0.00003580565,0.0007183377],"genre_scores_gemma":[0.00022013,0.9957666,0.000695474,0.0007010599,0.0004290496,0.001407543,0.0004088088,0.00007090149,0.0003003973],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.985895,"threshold_uncertainty_score":0.9997447,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0333971623598202,"score_gpt":0.4167466836523264,"score_spread":0.3833495212925062,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}